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Abstract
In this work, we utilize Machine Learning for early recognition of patients at high risk of acute respiratory distress
syndrome (ARDS), which is critical for successful prevention strategies for this devastating syndrome. The difficulty
in early ARDS recognition stems from its complex and heterogenous nature. In this study, we integrate knowledge of
the heterogeneity of ARDS patients into predictive model building. Using MIMIC-III data, we first apply latent class
analysis (LCA) to identify homogeneous sub-groups in the ARDS population, and then build predictive models on the
partitioned data. The results indicate that significantly improved performances of prediction can be obtained for two
of the three identified sub-phenotypes of ARDS. Experiments suggests that identifying sub-phenotypes is beneficial for
building predictive model for ARDS.
1 Introduction
The acute respiratory distress syndrome (ARDS) is a significant cause of morbidity and mortality in the USA and
worldwide1–4. While the mainstay of treatment is to treat the inciting cause of ARDS effectively, it is clear that
early, evidence-based management of ARDS can limit the propagation of lung injury and significantly improve patient
outcomes. Early management requires early identification. In 2012 an expert panel announced a new definition of
ARDS as the acute (within 7 days of a precipitant cause such as sepsis, trauma, etc.) development of abnormal
oxygenation and bilateral opacities in chest imaging consistent with pulmonary edema. However the reported ability
to predict mortality using this definition was at best modest with an AUC of 0.5775.
To date, there exists no reliable way to anticipate which patients are likely to develop ARDS. Numerous prediction
scores have been developed to assess ARDS prognosis and risk of death, such as the Lung Injury Score (LIS)6, Lung
Injury Prediction Score (LIPS)7, APPS (age, plateau, PaO2/FiO2) score8, Early Acute Lung Injury (EALI)9, and
Modified ARDS Prediction Score (MAPS)10. However, the predictive validities of these ARDS scoring tools have
been shown to be moderate: for example LIPS discriminated patients who developed Acute Lung Injury (ALI) from
those who did not with an AUC of 0.80 (95% CI, 0.770.84)7. MAPS was shown to have a similar AUC of 0.79 (95%
CI, 0.72 - 0.87) in predicting ARDS development10; the reported EALI AUC was 0.85 (95% CI: 0.80-0.91, (on the
training set) for identifying patients who progressed to acute lung injury9.
In identifying mortality, the predictive validity of LIS was found to be limited, with an AUC of 0.60 (95% CI 0.55 to
0.65), in the era of the Berlin definition11. Similarly APPS was found to have an AUC of 0.8 for predicting ARDS
mortality8. General illness severity scores, such as SAPS, SAPS II, APACHE II/III, and MPM, were also examined in
their ability in helping recognize ARDS early, but only similar moderate performance has been reported8, 9, 11.
Improved predictive validity is needed to enable reliable early identification and management of patients at risk for
ARDS. We hypothesize that a barrier to improved predictive performance of existing scoring tools may be the het-
erogeneity of the ARDS populations used to derive these models. Studies have indicated that ARDS is a highly
heterogeneous syndrome that may be composed of several distinct sub-phenotypes12–14. Such heterogeneity in pop-
ulation implies heterogeneity in relationships between explanatory and response variables within partitions, posing
serious challenges in predictive model building seeking to identify a common explanatory data pattern associated with
an outome15.
In this study, we integrate prior knowledge of the heterogeneity in ARDS population into predictive model building
by identifying ARDS subtypes that share common underlying pathophysiology as statistically expressed in observed
clinical data (e.g. labs, vitals). Specifically we utilize latent class analysis (LCA)16 to identify homogeneous sub-
groups of ARDS subjects14, and then build predictive models on partitioned data15 to see whether predictive validity
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could be improved, comparing with those from treating all patients as a whole homogeneous group. Prior work has
demonstrated the value of problem domain semantics in the enhancement of mortality risk predictive models17.
2 Material and Methods
2.1 Dataset
Clinical encounter data of adult patients (age ≥18 years) were extracted from the MIMIC- III version 1.4 ICU
database18. MIMIC-III consists of retrospective ICU encounter data of patients admitted into Beth Israel Deaconess
Medical Center from 2001 to 2012. Included ICUs are medical, surgical, trauma-surgical, coronary, cardiac surgery
recovery, and medical/surgical care units. Although MIMIC-III includes both time series data recorded in the EMR
during encounters (e.g. vital signs/diagnostic laboratory results, free text nursing notes/radiology reports, medica-
tions, discharge summaries, treatments, etc.) as well as high- resolution physiological data (time series / waveforms)
recorded by bedside monitors, only the time series data recorded in the EMR was used in this study.
2.1.1 Data for Latent Class Analysis
ICD-9 diagnosis codes and procedure codes identifying mechanically ventilated patients are the basis for identifying
the class of ARDS patients. PaO2, FiO2, and PEEP information were extracted from charted data. Time points of
ARDS onset are defined based on Berlin criteria5, i.e. PaO2/FiO2 ratio ≤ 300 with PEEP at least 5 cmH2O. The
observed vital and lab measurements after the identified diagnosis time are extracted, and features constructed as
class-defining variables in the LCA modelling including BMI, means of bicarbonate, plateau pressure, mean airway
pressure (MAP), PaCO2, tidal volume, platelet count, total bilirubin; minimum of sodium, glucose, albumin, hemat-
ocrit, systolic blood pressure (SBP); maximum of temperature, heart rate, white blood cell (WBC) count, creatinine;
and first-available PaO2/FiO2 ratio and PEEP (Table 1). Four predisposition conditions: sepsis, shock, aspiration, and
pneumonia, are also included in the LCA analysis.
2.1.2 Data for Predictive Modeling
Features considered in the predictive model building include: 1) vital signs: heart rate, respiratory rate, body tem-
perature, systolic blood pressure, diastolic blood pressure, mean arterial pressure, oxygen saturation, tidal volume; 2)
laboratory tests: white blood cell count, bands, hemoglobin, hematocrit, lactate, creatinine, bicarbonate, pH, PT, INR,
BUN, blood gas measurements (partial pressure of arterial oxygen, fraction of inspired oxygen, and partial pressure
of arterial carbon dioxide); 4) motor, verbal, and eye sub-score of Glasgow Coma Scale ; and 5) indicators of predis-
position factors and potential modifier: gender, sepsis, shock, trauma, pneumonia, high risk surgery, near drowning,
fracture, diabetes. See Appendix for a complete list of features with considered time ranges and properties of features.
2.2 Methods
2.2.1 Latent Class Analysis
Latent class model estimation is based on Gaussian finite mixture modelling methods19. It assumes that the popula-
tion is composed of a finite number of components. Mixture model parameters, i.e. components means, covariance
structure, and mixing weights, are obtained via the expectation maximization (EM) algorithm. Before LCA modeling,
Yeo-Johnson power transformation20 is applied to ensure approximate normality of continuous variables, and mean
imputation is used to replace missing values. To select a model fitting the data best, a series of latent class models with
different number of components are fitted, and Bayesian Information Criteria (BIC) is used for model selection.
2.2.2 Predictive Modeling
Predictive models, including gradient boosted machine (GBM)21 and random forest (RF)22, were built for all cases
and each phenotype separately, with all non ARDS subjects as the contrast group. Missing values were replaced by
medians of each variables. Synthetic Minority Over-Sampling Technique (SMOTE) is applied to resample data23.
Data was split into a training (70%) and test set (30%). Cross validation was used for tuning hyperparameters: number
Variable N missing Mean SD Minimum Median Maximum
Albumin** 1469 2.48 0.61 1 2.5 4.8
Bicarbonate** 99 24.86 5.32 6 25 46
Total Bilirubin** 1266 2.65 5.74 0.1 0.7 55.2
BMI 3287 42.48 261.26 5.51 27.82 7508.67
Highest Creatinine 97 1.02 0.99 0.1 0.7 9.9
Lowest Glucose 95 85.90 36.78 0.116 83 643
Lowest Hematocrit 92 25.81 5.18 2.1 25.1 55.5
Maximum Heart Rate 85 124.34 23.89 55 123 239
MAP** 307 10.89 4.09 2 10 41
PaCO2** 90 41.22 9.19 15 40 111.5
PaO2/FiO2 ratio* 0 253.94 192.23 21 225 5550
PEEP* 194 6.30 2.64 0.5 5 28
Plateau Pressure** 886 21.10 5.70 3 20 75
Platelet count** 113 236.95 144.21 9 218.5 1328
Lowest SBP 88 74.55 21.86 1 77 162
Lowest Sodium 75 134.39 5.90 3.5 135 165
Maximum Temperature 136 38.29 0.97 32.83 38.28 42.78
Tidal Volume** 435 505.28 93.08 1 500 999
Peak WBC 116 8.25 10.10 0.1 7 471.7
Table 1: Basic statistics of variables used in LCA, first available datapoints after ARDS onset. **: Mean of observed
values is extracted; *: First available measurement.
of trees, interaction depth, learning rate, minimum number of observations in nodes for GBM model; and number of
trees for RF model. Tuned models were used to evaluate performance of predicting sepsis in the test set. Confidence
intervals of performance metrics were obtained by bootstrapping method24. To compare performance (e.g. AUC)
between models, the method proposed by Delong et al.25 was applied, with the null hypothesis that the true difference
in performance metrics was equal to 0.
3 Results
3.1 Latent Class Analysis to Identify ARDS Sub-phenotypes
Data of 4181 ARDS patients (4714 ICU stays) were used in the LCA analysis classification was conducted without
consideration of clinical outcomes. Details on clinical variable selection, data cleaning and a complete list of the
clinical variables included in the LCA models are listed in Table 1. Unless specified, medians of measurements are
extracted. When value is missing values, median imputation is applied to each variable.
BIC criterion suggests a 3-component VEV model (i.e. ellipsoidal distribution, variable volume, equal shape, and
variable orientation) fits the data best (Figure 1). Numbers of ICU stays assigned into sub-phenotypes are 753 in
phenotype 1, 1471 in phenotype 2, 2490 in phenotype 3. Figure 2 shows differences in variables by phenotype
assignment. Figure 3 below shows mortality of each phenotype.
3.2 Predictive Models
Predictive models were built for all cases and each phenotype separately. Performances of predictive models evaluated
using validation set are listed in Table 2.
Comparisons between models for phenotypes and for all cases indicate that significant improvements in AUC over
existing predictive models are obtained for phenotype 1 and 2. Phenotype 3 was found to be the most difficult to
predict, with an AUC 90.9% using GBM. However, even in this case, it is still a great improvement when compared
to the LIPS score with a 81% AUC7.
Figure 1: Number of classes and corresponding BIC.
Figure 2: Differences in variables by phenotype assignment.
Figure 3: Mortality by sub-phenotype.
Phenotype Metrics GBM Random Forest P value
All AUC 0.904(0.897 - 0.911) 0.904(0.897 - 0.911) Reference
Sensitivity 0.905(0.837 - 0.931) 0.9(0.88 - 0.916)
Specificity 0.765(0.745 - 0.825) 0.782(0.768 - 0.799)
Accuracy 0.779(0.761 - 0.827) 0.793(0.781 - 0.807)
PPV 0.289(0.275 - 0.338) 0.303(0.291 - 0.317)
NPV 0.987(0.98 - 0.99) 0.987(0.984 - 0.989)
1 AUC 0.983(0.981 - 0.986) 0.985(0.983 - 0.987) < 0.0001*
Sensitivity 1(0.997 - 1) 1(0.995 - 1)
Specificity 0.952(0.948 - 0.957) 0.956(0.95 - 0.961)
Accuracy 0.953(0.949 - 0.957) 0.956(0.951 - 0.961)
PPV 0.231(0.218 - 0.25) 0.246(0.225 - 0.269)
NPV 1(1 - 1) 1(1 - 1)
2 AUC 0.986(0.984 - 0.988) 0.985(0.982 - 0.987) < 0.0001*
Sensitivity 0.982(0.97 - 0.994) 0.979(0.961 - 0.99)
Specificity 0.957(0.953 - 0.961) 0.955(0.938 - 0.96)
Accuracy 0.957(0.953 - 0.961) 0.956(0.939 - 0.961)
PPV 0.391(0.368 - 0.414) 0.382(0.31 - 0.411)
NPV 0.999(0.999 - 1) 0.999(0.999 - 1)
3 AUC 0.909(0.901 - 0.918) 0.902(0.892 - 0.911) 0.6538*
Sensitivity 0.902(0.829 - 0.93) 0.879(0.826 - 0.919)
Specificity 0.769(0.749 - 0.843) 0.773(0.733 - 0.82)
Accuracy 0.776(0.757 - 0.843) 0.778(0.742 - 0.821)
PPV 0.167(0.155 - 0.215) 0.165(0.148 - 0.191)
NPV 0.994(0.99 - 0.995) 0.992(0.989 - 0.994)
Table 2: Performance of predictive models. *: AUC is compared with that obtained with all data (labeled as refer-
ence).
4 Discussion
The study applied LCA to group ARDS patients into 3 sub-phenotypes and built separate predictive models for each
phenotype. Using routinely available clinical variables, our LCA analysis identified three classes of ARDS that had
different mortality rate, with sub phenotype 2 having significantly higher mortality (48%) than the other 2 types. Key
characteristics of phenotype 2 include high bilirubin (liver failure), high creatinine/high pulse pressure (heart/renal
failure), thrombocytopenia, lower minimum systolic blood pressure (hemodynamic instability), and lower PaO2/FiO2
indicating most severe respiratory failure. The identification of these subtypes may help triage ARDS patients that
respond differently to treatment (e.g. fluids). At a AUC of .98 for this high mortality subgroup, our results indicate
that significantly improved performance of prediction can be obtained for key ARDS sub-phenotypes.
It is known that heterogeneity in population poses a great challenge to predictive modeling. First, the training data
may be comprised of instances from not just one distribution, but several distributions juxtaposed together. In the
presence of multimodality within the classes, there may be imbalance among the distribution of different modes in
the training set. Hence, some of the modes may be underrepresented during training, resulting in poor performance
on those modes during the testing stage. Second, while some of the modes of a particular class may be easy to
distinguish from modes of the other class, there may be modes that participate in class confusion, i.e., reside in
regions of feature space that overlap with instances from other classes. The presence of such overlapping modes can
degrade the learning of any classification model trained across all modes of every class. Third, even if we are able
to learn a predictive model that shows reasonable performance on the training set, the test set may have a completely
different distribution of data instances than the training set, as the populations of training and test sets can be different.
Hence, the training performance can be quite misleading as it may not always be reflective of the performance on test
instances. Due to these reasons, identifying homogeneous subgroups within heterogeneous population mitigate the
impact of populations heterogeneity in predictive model building.
A limitation of MIMIC III is that inflammatory or genetic biomarker data was not available. Studies indicates they
may contribute in ARDS phenotyping12. Combining clinical data and biological data in LCA-based phenotyping may
improve homogeneities of ARDS sub-phenotypes, and further enhance predictive performance of machine learning
within subgroups.
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A Appendix
Identifier Distribution Volume Shape Orientation
EII Spherical equal equal NA
VII Spherical variable equal NA
EEI Diagonal equal equal coordinate axes
VEI Diagonal variable equal coordinate axes
EVI Diagonal equal variable coordinate axes
VVI Diagonal variable variable coordinate axes
EEE Ellipsoidal equal equal equal
EEV Ellipsoidal equal equal variable
VEV Ellipsoidal variable equal variable
VVV Ellipsoidal variable variable variable
Table 3: Models indexed in Figure 2.
Category Name Time Range Features Scale
Blood Chemistry Anion gap First 24 hours Minimum, Mean, Maximum Continuous
Albumin First 24 hours Minimum, Mean, Maximum Continuous
Albumin Across hospital stay Minimum Continuous
Bilirubin First 24 hours Minimum, Mean, Maximum Continuous
Creatinine First 24 hours Minimum, Mean, Maximum Continuous
Chloride First 24 hours Minimum, Mean, Maximum Continuous
Glucose First 24 hours Minimum, Mean, Maximum Continuous
Lactate First 24 hours Minimum, Mean, Maximum Continuous
Potassium First 24 hours Minimum, Mean, Maximum Continuous
Sodium First 24 hours Minimum, Mean, Maximum Continuous
BUN First 24 hours Minimum, Mean, Maximum Continuous
pH Across hospital stay Minimum Continuous
Blood Gas SpO2 First 24 hours Minimum, Mean, Maximum Continuous
PCO2 First 24 hours Minimum, Mean, Maximum Continuous
PO2 First 24 hours Minimum, Mean, Maximum Continuous
Bicarbonate First 24 hours Minimum, Mean, Maximum Continuous
Tidal volume First 24 hours Minimum, Mean, Maximum Continuous
Oxygen saturation First 24 hours Minimum, Mean, Maximum Continuous
FIO2 Across hospital stay Maximum Continuous
Hematology PTT First 24 hours Minimum, Mean, Maximum Continuous
INR First 24 hours Minimum, Mean, Maximum Continuous
PT First 24 hours Minimum, Mean, Maximum Continuous
WBC First 24 hours Minimum, Mean, Maximum Continuous
Hematocrit First 24 hours Minimum, Mean, Maximum Continuous
Bands First 24 hours Minimum, Mean, Maximum Continuous
Platelet First 24 hours Minimum, Mean, Maximum Continuous
Vital Heart Rate First 24 hours Minimum, Mean, Maximum Continuous
Systolic Blood Pressure First 24 hours Minimum, Mean, Maximum Continuous
Diastolic Blood Pressure First 24 hours Minimum, Mean, Maximum Continuous
Mean Airway Pressure First 24 hours Minimum, Mean, Maximum Continuous
Respiratory Rate First 24 hours Minimum, Mean, Maximum Continuous
Respiratory Rate Across hospital stay Maximum Continuous
Temperature First 24 hours Minimum, Mean, Maximum Continuous
GCS Total First 24 hours Minimum Continuous
GCS motor First 24 hours Minimum Continuous
GCS verbal First 24 hours Minimum Continuous
GCS eye First 24 hours Minimum Continuous
Output Urine Day 1, 2, 3 Continuous
Flag Alcohol abuse Binary(Yes/No)
Smoke Binary(Yes/No)
Chemotherapy Binary(Yes/No)
Sepsis Binary(Yes/No)
Shock Binary(Yes/No)
Trauma Binary(Yes/No)
High risk surgery Binary(Yes/No)
Pneumonia Binary(Yes/No)
Smoke Inhalation Binary(Yes/No)
Near Drowning Binary(Yes/No)
Fracture Binary(Yes/No)
Diabetes Binary(Yes/No)
Admission: Urgent Binary(Yes/No)
Admission: Emergency Binary(Yes/No)
Admission: Selective Binary(Yes/No)
Demographic Age Continuous
Gender Binary (F/M)
BMI Continuous
Table 4: Features used in predictive modeling.
